Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Change in Receivables: 2010-2025

Historic Change in Receivables for Mesa Laboratories (MLAB) over the last 16 years, with Sep 2025 value amounting to $1.7 million.

  • Mesa Laboratories' Change in Receivables fell 58.10% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $619,000, marking a year-over-year decrease of 42.36%. This contributed to the annual value of $2.9 million for FY2025, which is 159.21% up from last year.
  • As of Q3 2025, Mesa Laboratories' Change in Receivables stood at $1.7 million, which was up 149.36% from -$3.4 million recorded in Q2 2025.
  • In the past 5 years, Mesa Laboratories' Change in Receivables ranged from a high of $4.5 million in Q1 2022 and a low of -$6.5 million during Q2 2023.
  • Over the past 3 years, Mesa Laboratories' median Change in Receivables value was $142,000 (recorded in 2023), while the average stood at -$328,455.
  • Its Change in Receivables has fluctuated over the past 5 years, first crashed by 535.04% in 2023, then spiked by 2,261.97% in 2024.
  • Mesa Laboratories' Change in Receivables (Quarterly) stood at $3.3 million in 2021, then crashed by 120.40% to -$678,000 in 2022, then slumped by 319.76% to -$2.8 million in 2023, then skyrocketed by 76.91% to -$657,000 in 2024, then tumbled by 58.10% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, -$3.4 million for Q2 2025, and $3.0 million during Q1 2025.